MedTrace Logo

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

NCT00915096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2018-08-23

No results posted yet for this study

Summary

The purpose of the study is to assess in a prospective series of patients with high tumor burden follicular lymphoma treated with R-CHOP, the predictive value of \[18F\]-FDG PET performed over (after 4 treatments), and at the end of the first-line treatment on progression-free survival at 2 years.

Conditions

  • Lymphoma, Follicular

Sponsors & Collaborators

  • Lymphoma Study Association

    lead OTHER

Principal Investigators

  • Michel MEIGNAN, Prof · Lymphoma Study Association

  • Jehan DUPUIS, MD · Lymphoma Study Association

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-18
Primary Completion
2011-05-10
Completion
2013-02-08

Countries

  • France
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00915096 on ClinicalTrials.gov